Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
Challenges in the development of glaucoma neuroprotection therapy
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Challenges in the development of glaucoma neuroprotection therapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Glaucoma
100%
Neuroprotection Therapy
100%
Clinical Trials
66%
Intraocular Pressure
33%
Therapeutic Target
33%
Retina
33%
Optic Nerve
33%
Optic Neuropathy
33%
Major Risk Factors
33%
Disease Progression
33%
Pathogenic Mechanism
33%
Patient Samples
33%
Blindness
33%
New Therapies
33%
Retinopathy
33%
Unmet Medical Need
33%
Measurement Method
33%
Neuroprotective Treatment
33%
Mechanistic Research
33%
Endpoint Assessment
33%
Surrogate Endpoint
33%
Incomplete Understanding
33%
Pharmacology, Toxicology and Pharmaceutical Science
Glaucoma
100%
Neuroprotection
100%
Disease
100%
Clinical Trial
66%
Neuroprotective Agent
33%
Optic Nerve Disease
33%
Disease Exacerbation
33%
Retinopathy
33%
Neuroscience
Glaucoma
100%
Neuroprotection
100%
Intraocular Pressure
33%
Neuroprotective Agent
33%
Optic Nerve
33%
Optic Neuropathy
33%
Retinal Disease
33%
Clinical Method
33%